Recombinant Human NOV Protein，His

NOV (Nephroblastoma Overexpressed) is a member of the CCN protein family, which is known for its roles in cell proliferation, differentiation, and extracellular matrix remodeling. Originally identified as an oncogene implicated in nephroblastoma, research has demonstrated that NOV plays significant roles in various physiological and pathological processes, including tissue repair, fibrosis, and tumorigenesis. It is characterized by its cysteine-rich domains and the ability to interact with a variety of growth factors and receptors, influencing signaling pathways critical for cell adhesion and migration. Studies have indicated that altered expression levels of NOV are associated with several diseases, particularly cancers, making it a potential biomarker and therapeutic target. Recent advances in recombinant protein technology have allowed for the production of NOV in functional forms, facilitating the investigation of its biological activities. This has led to a deeper understanding of its mechanisms of action and interactions within the cellular microenvironment. Additionally, research into NOV's roles in cardiovascular diseases and its involvement in stem cell biology highlights its versatility and importance in both health and disease. As a result, NOV recombinant proteins are being explored for potential therapeutic applications, including tissue engineering and regenerative medicine. Understanding the full scope of NOV’s functions could lead to innovative strategies for diagnosing and treating various conditions, underscoring its relevance in both basic and applied biomedical research.